logo

For the Inventor, By the Inventor

Madison, WI, United States of America

Cellectar Biosciences, Inc.


USPTO Granted Patents = 10



Forward Citations = 27

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Jamey Paul Weichert (8 out of 45 patents)

silverMedal Anatoly Pinchuk (8 out of 30 patents)

bronzeMedal Marc Longino (8 out of 20 patents)

4.  Chorom Pak (5 out of 7 patents)

5.  Kevin Kozak (5 out of 5 patents)

6.  Joseph J Grudzinski (4 out of 6 patents)

7.  Benjamin Titz (4 out of 5 patents)

8.  Nathan Stehle (4 out of 4 patents)

9.  Jarrod Longcor (2 out of 2 patents)

10.  Irawati Kandela (1 out of 5 patents)

11.  William R Clarke (1 out of 7 patents)


10 patents:

1. 12503479 - Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy (2025-12-23),
2. 12496346 - Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy (2025-12-16),
3. 11467159 - Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells (2022-10-11),
4. 11439709 - Phospholipid ether analogs as cancer-targeting drug vehicles (2022-09-13),
5. 9925269 - Phospholipid ether analogs as cancer-targeting drug vehicles (2018-03-27),
6. 9616140 - Fluorescent phospholipid ether compounds, compositions, and methods of use (2017-04-11),
7. 9579406 - Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof (2017-02-28),
8. 9550002 - Phospholipid analogs as diapeutic agents and methods thereof (2017-01-24),
9. 9480754 - Phospholipid ether analogs as cancer-targeting drug vehicles (2016-11-01),
10. 9345718 - Phospholipid ether analogs as cancer-targeting drug vehicles (2016-05-24),
Cellectar Biosciences is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for cancer treatment. Their lead product candidate, CLR 131, is currently being evaluated in several clinical trials for a variety of cancers. The company's proprietary phospholipid drug conjugate platform enables the selective delivery of diverse oncologic payloads to cancer cells, offering a potentially more effective and less toxic treatment option for patients.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Cellectar Biosciences, Inc.
10 Patents

#68 in Madison, WI

#667 in Wisconsin

#29,802 in US

#55,915 in the World

Madison, WI (US)
Madison, WI, United States of America

Cellectar Biosciences, Inc.

Forward Citations = 27

11 inventors:

goldMedal Jamey Paul Weichert (8 out of 45 patents)

silverMedal Anatoly Pinchuk (8 out of 30 patents)

bronzeMedal Marc Longino (8 out of 20 patents)

4.  Chorom Pak (5 out of 7 patents)

5.  Kevin Kozak (5 out of 5 patents)

Please report any incorrect information to [email protected]
Loading…